Nature Communications (Nov 2023)

Modulation of insulin secretion by RBFOX2-mediated alternative splicing

  • Nicole D. Moss,
  • Kristen L. Wells,
  • Alexandra Theis,
  • Yong-Kyung Kim,
  • Aliya F. Spigelman,
  • Xiong Liu,
  • Patrick E. MacDonald,
  • Lori Sussel

DOI
https://doi.org/10.1038/s41467-023-43605-4
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Insulin secretion is a tightly regulated process that is vital for maintaining blood glucose homeostasis. Although the molecular components of insulin granule trafficking and secretion are well established, how they are regulated to rapidly fine-tune secretion in response to changing environmental conditions is not well characterized. Recent studies have determined that dysregulation of RNA-binding proteins (RBPs) and aberrant mRNA splicing occurs at the onset of diabetes. We demonstrate that the RBP, RBFOX2, is a critical regulator of insulin secretion through the alternative splicing of genes required for insulin granule docking and exocytosis. Conditional mutation of Rbfox2 in the mouse pancreas results in decreased insulin secretion and impaired blood glucose homeostasis. Consistent with defects in secretion, we observe reduced insulin granule docking and corresponding splicing defects in the SNARE complex components. These findings identify an additional mechanism for modulating insulin secretion in both healthy and dysfunctional pancreatic β cells.